Author: Stout, Robert L.; Rigatti, Steven J.
Title: HIV and the Seroprevalence of SARS-CoV-2 Cord-id: iztkl70u Document date: 2021_1_1
ID: iztkl70u
Snippet: ImportanceHealthy HIV-positive insurance applicants have a similar risk of infection and produce a similar antibody response as HIV-negative applicants infected with COVID-19. ObjectiveStudy the seroprevalence and immune response to COVID-19 in healthy HIV-positive life insurance applicants. DesignFrom January 2020 to March 2021, we examined the seroprevalence of COVID-19 in all HIV-positive applicants. Antibody level in 340 age and sex matched COVID-19 positive applicants, 170 HIV-positive and
Document: ImportanceHealthy HIV-positive insurance applicants have a similar risk of infection and produce a similar antibody response as HIV-negative applicants infected with COVID-19. ObjectiveStudy the seroprevalence and immune response to COVID-19 in healthy HIV-positive life insurance applicants. DesignFrom January 2020 to March 2021, we examined the seroprevalence of COVID-19 in all HIV-positive applicants. Antibody level in 340 age and sex matched COVID-19 positive applicants, 170 HIV-positive and 170 HIV negative, are compared. The data was de-identified of all personal information and separated by month, age and sex. ParticipantsSelf-reported healthy HIV positive life insurance applicants were tested for antibodies to COVID-19.
Search related documents:
Co phrase search for related documents- Try single phrases listed below for: 1
Co phrase search for related documents, hyperlinks ordered by date